Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates
Grief symptom trajectories serve as early indicators of future health care use, psychotropic medication needs, and mortality risk in bereaved individuals.